NORMOXYS, INC.

Profile

Company Names

NORMOXYS, INC.
NORMOXYS INC

Addresses

300 MARKET STREET, BOSTON, MA 02135

16 LAUREL AVENUE, SUITE 150, WELLESELY, MA 02481

16 LAUREL AVENUE, SUITE 150, WELLESLEY, MA 02481

300 MARKET STREET, BRIGHTON, MA 02135

Phone Numbers

617-719-9489
339-686-7354

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2004

State Incorporated:

DE

Total Amount Raised:

$25,277,445.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2011-11-07 
$600,000.00 
$1,100,000.00 
$500,000.00 
Debt 
4
2011-06-10 
$1,556,353.00 
$1,687,587.00 
$131,234.00 
Debt 
3
2010-05-10 
$17,564,384.00 
$17,564,384.00 
$0.00 
Equity 
2
2010-03-21 
$1,050,000.00 
$1,050,000.00 
$0.00 
Debt 
1
2009-04-22 
$4,506,708.00 
$4,506,708.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CONRAD 
 
BLETZER, JR. 
EXECUTIVE OFFICER
CONRAD 
J. 
BLETZER, JR. 
EXECUTIVE OFFICER, DIRECTOR
FRANCESCO 
 
DE RUBERTIS 
DIRECTOR
DR. JEAN-PIERRE 
 
GARNIER 
DIRECTOR
JEAN-PIERRE 
 
GARNIER 
DIRECTOR
ARGERIS 
 
KARABELAS 
DIRECTOR
JEAN-MARIE 
 
LEHN 
DIRECTOR
SARA 
 
MCKENZIE 
EXECUTIVE OFFICER
CLAUDE 
 
NICOLAU 
DIRECTOR, EXECUTIVE OFFICER
MARTIN 
 
TOLAR 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#